Teva for Two: Federal Circuit Doubles Up On De Novo Review

/ 0 Comments

In Teva Pharmaceuticals v. Sandoz, the Supreme Court said that in patent cases, like any other civil case, the court of appeals must show deference to the trial court’s findings of fact, even if those findings relate to the legal issue of the proper construction of claim language in a patent. In reporting on that...

Read More
separator

Supreme Court Uncertain On Claim Construction Standard

/ 0 Comments

The Supreme Court’s new term got off to a hot start in the patent field with Teva Pharmaceuticals v. Sandoz. At oral argument on October 15, 2014, the justices wrestled with themselves and each other over how to weigh competing interests and rules in a case that could, depending on the outcome, change patent litigation...

Read More
separator